Drug Trial Radar · NCT06911502
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Last checked: Nov 19, 2026Latest source record: May 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Jul 28, 2025
Primary completion
Apr 24, 2028
Study completion Jul 31, 2030
Sponsor
- Lead sponsor
- CelgeneBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Apr 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed as a multicenter, randomized, open label Phase 3 study to compare the efficacy and safety of golcadomide in combination with rituximab vs investigator's choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy.
Conditions
- Follicular Lymphoma
Interventions
GolcadomideDrug
Specified dose on specified days
RituximabDrug
Specified dose on specified days
LenalidomideDrug
Specified dose on specified days
CyclophosphamideDrug
Specified dose on specified days
DoxorubicinDrug
Specified dose on specified days
VincristineDrug
Specified dose on specified days
Prednisone/PrednisoloneDrug
Specified dose on specified days
BendamustineDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression free survival (PFS) assessed by Independent Review Adjudication committee (IRAC)Time frame: Up to approximately 32 Months
Locations
160 sites in 21 countries. Site status is shown where the registry gives one.
Local Institution - 0225
Birmingham, Alabama · Not yet recruiting
Infirmary Cancer Care
Mobile, Alabama · Recruiting
Alaska Oncology and Hematology
Anchorage, Alaska · Recruiting
Local Institution - 0215
Little Rock, Arkansas · Not yet recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Recruiting
UCSF Helen Diller Medical Center at Parnassus Heights
San Francisco, California · Recruiting
Local Institution - 0008
Jacksonville, Florida · Not yet recruiting
Local Institution - 0214
Tampa, Florida · Not yet recruiting
Local Institution - 0217
Tampa, Florida · Not yet recruiting
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
Marietta, Georgia · Recruiting
Southeastern Regional Medical Center
Newnan, Georgia · Recruiting
Local Institution - 0240
Arlington Heights, Illinois · Not yet recruiting
Local Institution - 0253
Iowa City, Iowa · Not yet recruiting
Local Institution - 0243
Waukee, Iowa · Not yet recruiting
Local Institution - 0216
Westwood, Kansas · Not yet recruiting
Local Institution - 0218
Lexington, Kentucky · Not yet recruiting
Local Institution - 0023
Baltimore, Maryland · Not yet recruiting
Greater Baltimore Medical Center
Towson, Maryland · Recruiting
Local Institution - 0145
Boston, Massachusetts · Not yet recruiting
Local Institution - 0244
Boston, Massachusetts · Not yet recruiting
Local Institution - 0247
Boston, Massachusetts · Not yet recruiting
Hattiesburg Clinic Hematology/Oncology
Hattiesburg, Mississippi · Recruiting
Local Institution - 0144
Providence, Rhode Island · Not yet recruiting
Texas Oncology - Central/South Texas
Austin, Texas · Recruiting
Local Institution - 0212
Fort Worth, Texas · Not yet recruiting
Local Institution - 0230
San Antonio, Texas · Not yet recruiting
Texas Oncology - Northeast Texas
Tyler, Texas · Recruiting
Local Institution - 0238
Fairfax, Virginia · Not yet recruiting
Hematology Oncology Associates of Fredericksburg
Fredericksburg, Virginia · Recruiting
Blue Ridge Cancer Care
Roanoke, Virginia · Recruiting
Local Institution - 0143
Vancouver, Washington · Not yet recruiting
Westmead Hospital
Westmead, New South Wales, Australia · Recruiting
Local Institution - 0132
Adelaide, South Australia, Australia · Not yet recruiting
Local Institution - 0131
Hobart, Tasmania, Australia · Not yet recruiting
Local Institution - 0128
Heidelberg, Victoria, Australia · Not yet recruiting
Cabrini Hospital - Malvern
Malvern, Victoria, Australia · Recruiting
Local Institution - 0127
Perth, Western Australia, Australia · Not yet recruiting
Local Institution - 0224
Perth, Western Australia, Australia · Withdrawn
Local Institution - 0089
Rio de Janeiro, Brazil · Not yet recruiting
Local Institution - 0066
São Paulo, Brazil · Not yet recruiting
Showing 40 of 160 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.